↓ Skip to main content

Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs

Overview of attention for article published in BMC Cancer, November 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

twitter
15 tweeters
facebook
2 Facebook pages

Citations

dimensions_citation
73 Dimensions

Readers on

mendeley
98 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs
Published in
BMC Cancer, November 2011
DOI 10.1186/1471-2407-11-478
Pubmed ID
Authors

Florence Ranchon, Gilles Salles, Hans-Martin Späth, Vérane Schwiertz, Nicolas Vantard, Stéphanie Parat, Florence Broussais, Benoît You, Sophie Tartas, Pierre Jean Souquet, Claude Dussart, Claire Falandry, Emilie Henin, Gilles Freyer, Catherine Rioufol

Abstract

In spite of increasing efforts to enhance patient safety, medication errors in hospitalised patients are still relatively common, but with potentially severe consequences. This study aimed to assess antineoplastic medication errors in both affected patients and intercepted cases in terms of frequency, severity for patients, and costs.

Twitter Demographics

The data shown below were collected from the profiles of 15 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 98 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 2%
Brazil 2 2%
Spain 1 1%
Unknown 93 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 15 15%
Researcher 14 14%
Student > Ph. D. Student 10 10%
Other 9 9%
Student > Postgraduate 8 8%
Other 25 26%
Unknown 17 17%
Readers by discipline Count As %
Medicine and Dentistry 23 23%
Pharmacology, Toxicology and Pharmaceutical Science 20 20%
Nursing and Health Professions 9 9%
Social Sciences 4 4%
Business, Management and Accounting 3 3%
Other 13 13%
Unknown 26 27%

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 March 2015.
All research outputs
#737,937
of 7,318,850 outputs
Outputs from BMC Cancer
#169
of 3,220 outputs
Outputs of similar age
#8,247
of 86,989 outputs
Outputs of similar age from BMC Cancer
#3
of 89 outputs
Altmetric has tracked 7,318,850 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,220 research outputs from this source. They receive a mean Attention Score of 3.3. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 86,989 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 89 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.